Ketoconazole cream 2% formulation pharmaceutical manufacturing bom?

Below is a sample Bill‑of‑Materials (BOM) for a 2 % ketoconazole cream that can be used as a starting point for a pharmaceutical manufacturing process.
The data are illustrative; you should confirm all quantities, specifications, and regulatory requirements with your own quality‑control, GMP, and regulatory teams before using the formula in production.

---

1. Active Pharmaceutical Ingredient (API)

Item	Code	Typical Specification	Qty (g)	Notes
Ketoconazole	KET	USP, ≥ 99 % purity, ≤ 0.05 % residual solvents	20 g (2 % w/w in 1 000 g batch)	Source from a GMP‑registered supplier.
Ketoconazole (powder)	KET‑P	≤ 1 % moisture, ≤ 0.05 % inorganic residue	20 g	Use a dry‑powder form for better dispersion.

---

2. Emulsion Base / Cream Matrix

Item	Code	Typical Specification	Qty (g)	Notes
Petrolatum (soft paraffin)	PET	USP, ≤ 0.5 % residual solvents	400 g	Provides occlusive base and improves spreadability.
White Soft Paraffin (Sparingly used)	WSP	≤ 0.2 % residual solvents	100 g	Helps to stabilize the emulsion.
Polysorbate 20 (Tween‑20)	P20	USP, ≤ 0.2 % residual solvents	30 g	Primary surfactant; soluble in oil.
Glyceryl Stearate SE	GSS	USP, ≤ 0.05 % residual solvents	25 g	Co‑surfactant; helps form stable emulsion.
Cetostearyl Alcohol	CA	USP, ≤ 0.1 % residual solvents	15 g	Thickener and emulsifier.
Stearic Acid	SA	USP, ≤ 0.1 % residual solvents	15 g	Helps to solidify the cream at room temperature.

---

3. Solvents & Dilutants (if any)

Item	Code	Spec	Qty (g)	Notes
Propylene Glycol	PG	USP, ≤ 0.01 % residual solvents	10 g	Improves drug penetration and stabilizes the emulsion.
Ethyl Alcohol (95 %)	EA	≤ 0.05 % residual solvents	5 g	Optional; used in some formulations to increase potency.

---

4. Preservatives & Antimicrobial (if needed)

Item	Code	Spec	Qty (g)	Notes
Benzalkonium Chloride	BKC	USP, ≤ 0.01 % residual solvents	0.5 g	Optional, especially for preservative‑free formulations.

---

5. pH Adjusters & Stabilizers

Item	Code	Spec	Qty (g)	Notes
Citric Acid	CA	USP, ≤ 0.01 % residual solvents	1 g	To adjust pH to 5.5–6.5.
Sodium Hydroxide	NaOH	USP, ≤ 0.01 % residual solvents	0.5 g	For pH correction.

---

6. Additional Additives (optional, based on product profile)

Item	Code	Spec	Qty (g)	Notes
Glycerin	Glycer	USP, ≤ 0.01 % residual solvents	10 g	Humectant, improves skin feel.
Lanolin	LAN	USP, ≤ 0.01 % residual solvents	5 g	Provides additional occlusion.
Tocopherol (Vitamin E)	TOC	USP, ≤ 0.01 % residual solvents	0.2 g	Antioxidant, extends shelf life.

---

7. Process Summary (High‑level)

Step	Description	Key Parameters
1. Weighing & Mixing	Weigh all dry excipients (excluding ketoconazole). Blend in a clean, dry mixing vessel until homogeneous.	Use a twin‑screw extruder or high‑shear mixer.
2. Melting	Melt petrolatum, white soft paraffin, and cetostearyl alcohol at 70–80 °C.	Maintain below 90 °C to avoid ketoconazole degradation.
3. Incorporate Surfactants	Add polysorbate 20, glyceryl stearate SE, stearic acid, and any optional surfactants to the melt while stirring.	Keep temperature 60–70 °C.
4. Add the API	Gradually sprinkle ketoconazole powder into the molten base while stirring to avoid clumping.	Ensure uniform distribution; use a mechanical stirrer at 200–300 rpm.
5. Cool & Emulsify	Cool to 40–45 °C and add water phase (propylene glycol, glycerin, pH adjuster, preservatives) while mixing.	Use a high‑shear mixer or homogenizer to form a stable oil‑in‑water emulsion.
6. Adjust pH & Add Final Additives	Adjust pH to 5.5–6.5 with citric acid or NaOH. Add tocopherol, lanolin, or other optional additives.	Verify pH with calibrated pH meter.
7. Quality Control	Test for appearance, consistency, pH, drug content, sterility (if required), and microbial limit.	Follow USP <1170> for emulsion quality checks.
8. Packaging	Fill into amber glass or HDPE containers, seal, and label.	Ensure packaging protects from light and moisture.

---

8. Key Regulatory & Safety Notes

1. GMP Compliance – All equipment, personnel, and facilities must meet GMP standards.
2. Residue Solvent Limits – Verify each excipient meets USP residue solvent limits for pharmaceutical preparations.
3. Stability – Conduct accelerated stability studies (25 °C/60 % RH, 40 °C/75 % RH) to determine shelf‑life.
4. Microbial Testing – For non‑preservative formulations, perform preservative efficacy testing (PET) and routine microbiological limits (USP <1170>).
5. Allergen & Irritant Assessment – Screen for potential skin irritation; perform patch testing if necessary.
6. Environmental & Disposal – Follow local regulations for disposing of ketoconazole waste and solvent residues.

---

9. Sample Batch Sheet (1 000 g)

Component	Quantity (g)	% w/w
Ketoconazole	20	2.0
Petrolatum	400	40.0
White Soft Paraffin	100	10.0
Polysorbate 20	30	3.0
Glyceryl Stearate SE	25	2.5
Cetostearyl Alcohol	15	1.5
Stearic Acid	15	1.5
Propylene Glycol	10	1.0
Glycerin	10	1.0
Citric Acid	1	0.1
Sodium Hydroxide	0.5	0.05
Benzalkonium Chloride	0.5	0.05
Tocopherol	0.2	0.02
Total	1 000	100.0

(Percentages may be adjusted slightly to maintain 100 % total; minor rounding differences are acceptable.)

---

Final Tips

• Batch Record & SOPs – Document every step; deviations must be recorded and justified.
• Scale‑Up – When scaling beyond pilot batch, re‑evaluate mixing times, heat transfer, and emulsion stability.
• Documentation – Maintain a full formulation dossier (including safety data sheets, regulatory status, and stability data) for regulatory submissions.

Feel free to tweak the excipients or concentrations to meet your